German court: Syrian man guilty of crimes against humanity

A German court has convicted a former Syrian secret police officer of crimes against humanity for overseeing the abuse of detainees at a jail near Damascus a decade ago

Via AP news wire
Thursday 13 January 2022 09:39
Germany Syria Torture Trial
Germany Syria Torture Trial

A German court has convicted a former Syrian secret police officer of crimes against humanity for overseeing the abuse of detainees at a jail near Damascus a decade ago.

The verdict Thursday in the landmark trial has been keenly anticipated by Syrians who suffered abuse or lost relatives at the hands of President Bashar Assad’s government in the country’s long-running conflict.

The Koblenz state court concluded that Anwar Raslan was the senior officer in charge of a facility in the Syrian city of Douma known as Al Khatib, or Branch 251, where suspected opposition protesters were detained.

It sentenced him to life in prison, German broadcaster n-tv reported. His lawyers asked the court last week to acquit their client, claiming that he never personally tortured anybody and that he defected in late 2012.

German prosecutors alleged that Raslan supervised the “systematic and brutal torture” of more than 4,000 prisoners between April 2011 and September 2012, resulting in the deaths of dozens of people.

A junior officer, Eyad al-Gharib, was convicted last year of accessory to crimes against humanity and sentenced by the Koblenz court to 4½ years in prison.

Both men were arrested in Germany in 2019, years after seeking asylum in the country.

Victims and human rights groups have said they hope the verdict will be a first step toward justice for countless people who have been unable to file criminal complaints against officials in Syria or before the International Criminal Court

Since Russia and China have blocked efforts for the U.N. Security Council to refer cases to The Hague-based tribunal, countries such as Germany that apply the principle of universal jurisdiction for serious crimes will increasingly become the venue for such trials, experts say.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in